Published DateClear

Start Date

End Date

Category

• Business1
• Pipeline1

Organizations

• Bausch + Lomb80
• Eyes On Eyecare59
• Alcon, Inc.53
• American Optometric Association44
• Harrow35
• Glaukos31
• Topcon Healthcare26
• Regeneron25
• Coopervision23
• Aldeyra Therapeutics21

Tags

• CEO1
• Cell Therapy1
• Eye Drop Solution1
• Eye Drops1
• Finance1
• Financial1
• Leadership1
• Stem Cell Therapy1

• Organizations: Claris Bio✕

Clear all

Business

Leadership watch: Samsara, Claris Bio, Staar Surgical, Wills Eye, and more

Leadership changes are underway in the eyecare space—and we’ve got the latest.

Pipeline

Claris Bio raises $118M to advance first-ever LSCD therapy

Financing to support ongoing and planned clinical trials evaluating CSB-001 (oremepermin alfa ophthalmic solution) as a topical ocular biologic eye drop.